| pubmed-article:1615140 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:1615140 | lifeskim:mentions | umls-concept:C0086418 | lld:lifeskim |
| pubmed-article:1615140 | lifeskim:mentions | umls-concept:C0011812 | lld:lifeskim |
| pubmed-article:1615140 | lifeskim:mentions | umls-concept:C0021467 | lld:lifeskim |
| pubmed-article:1615140 | lifeskim:mentions | umls-concept:C0178602 | lld:lifeskim |
| pubmed-article:1615140 | lifeskim:mentions | umls-concept:C0021469 | lld:lifeskim |
| pubmed-article:1615140 | lifeskim:mentions | umls-concept:C0205171 | lld:lifeskim |
| pubmed-article:1615140 | lifeskim:mentions | umls-concept:C0205275 | lld:lifeskim |
| pubmed-article:1615140 | pubmed:issue | 2-3 | lld:pubmed |
| pubmed-article:1615140 | pubmed:dateCreated | 1992-7-30 | lld:pubmed |
| pubmed-article:1615140 | pubmed:abstractText | The performance of healthy volunteer subjects on an auditory latent inhibition (LI) paradigm was assessed following administration of a single oral dose of d-amphetamine or placebo. It was predicted that a low (5 mg), but not a high (10 mg), dose of d-amphetamine would disrupt LI. The prediction was supported with left ear presentation of the preexposed stimulus only. When the preexposed stimulus was presented to the right ear the predicted pattern of findings was not obtained. It is concluded that the dopaminergic system is involved in the mediation of LI in man and it is speculated that the interaction between amphetamine dose and ear of presentation of the preexposed stimulus may reflect normally occurring dopaminergic hemisphere asymmetry. | lld:pubmed |
| pubmed-article:1615140 | pubmed:language | eng | lld:pubmed |
| pubmed-article:1615140 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:1615140 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:1615140 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:1615140 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:1615140 | pubmed:issn | 0033-3158 | lld:pubmed |
| pubmed-article:1615140 | pubmed:author | pubmed-author:GrayJ AJA | lld:pubmed |
| pubmed-article:1615140 | pubmed:author | pubmed-author:DawlingSS | lld:pubmed |
| pubmed-article:1615140 | pubmed:author | pubmed-author:HemsleyD RDR | lld:pubmed |
| pubmed-article:1615140 | pubmed:author | pubmed-author:PickeringA... | lld:pubmed |
| pubmed-article:1615140 | pubmed:author | pubmed-author:GrayN SNS | lld:pubmed |
| pubmed-article:1615140 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:1615140 | pubmed:volume | 107 | lld:pubmed |
| pubmed-article:1615140 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:1615140 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:1615140 | pubmed:pagination | 425-30 | lld:pubmed |
| pubmed-article:1615140 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:1615140 | pubmed:meshHeading | pubmed-meshheading:1615140-... | lld:pubmed |
| pubmed-article:1615140 | pubmed:meshHeading | pubmed-meshheading:1615140-... | lld:pubmed |
| pubmed-article:1615140 | pubmed:meshHeading | pubmed-meshheading:1615140-... | lld:pubmed |
| pubmed-article:1615140 | pubmed:meshHeading | pubmed-meshheading:1615140-... | lld:pubmed |
| pubmed-article:1615140 | pubmed:meshHeading | pubmed-meshheading:1615140-... | lld:pubmed |
| pubmed-article:1615140 | pubmed:meshHeading | pubmed-meshheading:1615140-... | lld:pubmed |
| pubmed-article:1615140 | pubmed:meshHeading | pubmed-meshheading:1615140-... | lld:pubmed |
| pubmed-article:1615140 | pubmed:meshHeading | pubmed-meshheading:1615140-... | lld:pubmed |
| pubmed-article:1615140 | pubmed:meshHeading | pubmed-meshheading:1615140-... | lld:pubmed |
| pubmed-article:1615140 | pubmed:meshHeading | pubmed-meshheading:1615140-... | lld:pubmed |
| pubmed-article:1615140 | pubmed:year | 1992 | lld:pubmed |
| pubmed-article:1615140 | pubmed:articleTitle | Abolition of latent inhibition by a single 5 mg dose of d-amphetamine in man. | lld:pubmed |
| pubmed-article:1615140 | pubmed:affiliation | Department of Psychology, Institute of Psychiatry, London, UK. | lld:pubmed |
| pubmed-article:1615140 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:1615140 | pubmed:publicationType | Clinical Trial | lld:pubmed |
| pubmed-article:1615140 | pubmed:publicationType | Randomized Controlled Trial | lld:pubmed |
| pubmed-article:1615140 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:1615140 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:1615140 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:1615140 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:1615140 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:1615140 | lld:pubmed |
